1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Babu, C.R. Flynn, P.F. Wand, A.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Am.Chem.Soc. JACSAT 0004 0002-7863 123 2691 2692 10.1021/ja005766d 11456950 Validation of protein structure from preparations of encapsulated proteins dissolved in low viscosity fluids. 2001 US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 95 15299 15302 10.1073/pnas.95.26.15299 High-resolution NMR of encapsulated proteins dissolved in low-viscosity fluids 1998 NE J.Biomol.NMR JBNME9 0800 0925-2738 14 75 78 10.1023/A:1008354507250 Preparation of encapsulated proteins dissolved in low viscosity fluids 1999 10.2210/pdb1g6j/pdb pdb_00001g6j 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 8576.831 UBIQUITIN 1 man polymer no no MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia Escherichia coli sample 9606 Homo sapiens 469008 Escherichia coli BL21(DE3) BL21(DE3) PET PET15 database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2001-03-28 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name crystal structure of ubiquitin structure of ubiquitin in aqueous buffer RCSB Y RCSB 2000-11-06 REL REL lowest target function values 100 32 3D_13C-separated_NOESY 3D_15N-separated_NOESY HNHA ambient 293 K 50 psi 293 K The structures are based on 1805 NOEs and 63 phi restraints torsion angle dynamics using DYANA 25 closest to the average 4 mg c13/n15 ubiquitin in 13.5 ul of buffer (50mM Sodium acetate, 250mM Sodium Chloride, pH 5.0) and 1 ml D12-pentane 75mM bis(2-ethyl hexyl) sulfosuccinate in d-pentane 8 mg 13/n15 ubiquitin in 27 ul of buffer (50mM Sodium acetate, 250mM Sodium Chloride, pH 5.0) 75mM bis(2-ethyl hexyl) sulfosuccinate in butane 4 mg n15 ubiquitin in 13.5 ul of buffer (50mM Sodium acetate, 250mM Sodium Chloride, pH 5.0) 75mM bis(2-ethyl hexyl) sulfosuccinate in d-pentane Guntert, P., Mumenthaler, C., Wuthrich, K. refinement DYANA 1.5 MSI, San Diego, CA processing Felix 97 Bartels, C.X., Guntert, P., Billeter, M., Wuthrich, K. data analysis XEASY 1.2 750 Varian INOVA 600 Varian INOVA MET 1 n 1 MET 1 A GLN 2 n 2 GLN 2 A ILE 3 n 3 ILE 3 A PHE 4 n 4 PHE 4 A VAL 5 n 5 VAL 5 A LYS 6 n 6 LYS 6 A THR 7 n 7 THR 7 A LEU 8 n 8 LEU 8 A THR 9 n 9 THR 9 A GLY 10 n 10 GLY 10 A LYS 11 n 11 LYS 11 A THR 12 n 12 THR 12 A ILE 13 n 13 ILE 13 A THR 14 n 14 THR 14 A LEU 15 n 15 LEU 15 A GLU 16 n 16 GLU 16 A VAL 17 n 17 VAL 17 A GLU 18 n 18 GLU 18 A PRO 19 n 19 PRO 19 A SER 20 n 20 SER 20 A ASP 21 n 21 ASP 21 A THR 22 n 22 THR 22 A ILE 23 n 23 ILE 23 A GLU 24 n 24 GLU 24 A ASN 25 n 25 ASN 25 A VAL 26 n 26 VAL 26 A LYS 27 n 27 LYS 27 A ALA 28 n 28 ALA 28 A LYS 29 n 29 LYS 29 A ILE 30 n 30 ILE 30 A GLN 31 n 31 GLN 31 A ASP 32 n 32 ASP 32 A LYS 33 n 33 LYS 33 A GLU 34 n 34 GLU 34 A GLY 35 n 35 GLY 35 A ILE 36 n 36 ILE 36 A PRO 37 n 37 PRO 37 A PRO 38 n 38 PRO 38 A ASP 39 n 39 ASP 39 A GLN 40 n 40 GLN 40 A GLN 41 n 41 GLN 41 A ARG 42 n 42 ARG 42 A LEU 43 n 43 LEU 43 A ILE 44 n 44 ILE 44 A PHE 45 n 45 PHE 45 A ALA 46 n 46 ALA 46 A GLY 47 n 47 GLY 47 A LYS 48 n 48 LYS 48 A GLN 49 n 49 GLN 49 A LEU 50 n 50 LEU 50 A GLU 51 n 51 GLU 51 A ASP 52 n 52 ASP 52 A GLY 53 n 53 GLY 53 A ARG 54 n 54 ARG 54 A THR 55 n 55 THR 55 A LEU 56 n 56 LEU 56 A SER 57 n 57 SER 57 A ASP 58 n 58 ASP 58 A TYR 59 n 59 TYR 59 A ASN 60 n 60 ASN 60 A ILE 61 n 61 ILE 61 A GLN 62 n 62 GLN 62 A LYS 63 n 63 LYS 63 A GLU 64 n 64 GLU 64 A SER 65 n 65 SER 65 A THR 66 n 66 THR 66 A LEU 67 n 67 LEU 67 A HIS 68 n 68 HIS 68 A LEU 69 n 69 LEU 69 A VAL 70 n 70 VAL 70 A LEU 71 n 71 LEU 71 A ARG 72 n 72 ARG 72 A LEU 73 n 73 LEU 73 A ARG 74 n 74 ARG 74 A GLY 75 n 75 GLY 75 A GLY 76 n 76 GLY 76 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N LEU 15 A N LEU 15 A O ILE 3 A O ILE 3 A N PHE 4 A N PHE 4 A O SER 65 A O SER 65 A N VAL 70 A N VAL 70 A O ARG 42 A O ARG 42 A N PHE 45 A N PHE 45 A O LYS 48 A O LYS 48 2 A A H OD2 GLU ASP 18 21 1.54 2 A A O H ILE GLU 30 34 1.58 6 A A H OD2 GLU ASP 18 21 1.53 7 A A H OD2 GLU ASP 18 21 1.55 8 A A H OD2 GLU ASP 18 21 1.55 8 A A O H GLU ARG 51 54 1.56 8 A A O HG GLN SER 62 65 1.57 8 A A O H ILE GLU 30 34 1.58 9 A A H OD2 GLU ASP 18 21 1.53 10 A A H OD2 GLU ASP 18 21 1.57 11 A A H OD2 GLU ASP 18 21 1.54 11 A A OE1 HG GLN SER 62 65 1.55 12 A A H OD2 GLU ASP 18 21 1.55 13 A A H OH GLU TYR 51 59 1.55 15 A A H OD2 GLU ASP 18 21 1.52 16 A A H OD2 GLU ASP 18 21 1.54 16 A A O HG GLN SER 62 65 1.56 16 A A H O MET VAL 1 17 1.59 19 A A H OD2 GLU ASP 18 21 1.54 20 A A H OD2 GLU ASP 18 21 1.55 22 A A H OD2 GLU ASP 18 21 1.55 23 A A O HG GLN SER 62 65 1.60 24 A A H OD2 GLU ASP 18 21 1.55 25 A A HE22 O GLN ARG 40 74 1.57 26 A A H OD2 GLU ASP 18 21 1.53 27 A A H OD2 GLU ASP 18 21 1.54 27 A A O H PHE LYS 45 48 1.59 28 A A H OD2 GLU ASP 18 21 1.52 29 A A H OD2 GLU ASP 18 21 1.53 30 A A H OD2 GLU ASP 18 21 1.53 31 A A H OD2 GLU ASP 18 21 1.55 32 A A O H GLU ARG 51 54 1.51 1 A LYS 33 -77.13 -73.21 1 A LEU 73 -80.05 -72.95 1 A ARG 74 -86.20 -149.56 2 A LYS 33 -79.10 -70.03 2 A ASP 52 -47.41 104.76 2 A ARG 74 -90.16 -153.50 3 A LYS 33 -74.72 -73.05 3 A ASP 52 -47.01 104.00 3 A ARG 74 -90.19 -149.98 4 A LYS 33 -74.84 -73.02 4 A ASP 52 -47.17 104.22 4 A ARG 74 -90.15 -150.69 5 A THR 9 -99.73 44.41 5 A LYS 33 -75.41 -74.81 5 A ASP 52 -46.96 102.65 5 A ARG 74 -90.11 -150.02 6 A LYS 33 -79.73 -71.13 6 A ASP 52 -47.05 105.63 6 A ARG 74 -90.39 -156.27 7 A LYS 33 -74.41 -75.12 7 A ARG 74 -90.10 -149.94 8 A ARG 74 -90.25 -150.18 9 A LYS 33 -77.29 -74.94 9 A LEU 73 -78.55 -73.56 10 A THR 9 -99.71 39.87 10 A LYS 33 -74.74 -77.50 10 A ASP 52 -46.77 104.00 10 A LEU 73 -79.45 -71.96 10 A ARG 74 -90.34 -150.32 11 A ASP 52 -47.42 104.81 11 A ASN 60 60.85 66.20 11 A LEU 73 -79.58 -70.84 11 A ARG 74 -90.09 -150.03 12 A THR 9 -99.48 43.82 12 A LYS 33 -74.73 -72.46 12 A ASP 52 -47.35 104.01 12 A LEU 73 -77.30 -71.28 12 A ARG 74 -90.35 -153.70 13 A LYS 33 -74.64 -74.87 13 A ARG 74 -90.07 -150.21 14 A LYS 33 -74.58 -71.53 14 A ASP 52 -47.41 106.35 14 A ARG 74 -87.44 -149.93 15 A LYS 33 -75.07 -78.23 15 A ASP 52 -47.39 104.62 15 A ASN 60 62.57 66.19 15 A ARG 74 -90.31 -151.25 16 A LYS 33 -78.76 -77.45 16 A ARG 74 -90.23 -150.83 17 A LYS 33 -75.11 -75.44 17 A ALA 46 55.02 19.87 17 A ASP 52 -47.16 103.39 17 A LEU 73 -76.11 -73.44 17 A ARG 74 -90.20 -150.07 18 A LYS 33 -78.51 -72.94 18 A ASP 52 -47.03 103.09 18 A ARG 74 -90.08 -149.96 19 A LYS 33 -80.39 -74.68 19 A ASP 52 -47.13 104.99 19 A ARG 74 -90.14 -150.17 20 A LYS 33 -74.80 -78.01 20 A ALA 46 58.60 17.92 20 A ASP 52 -47.27 103.51 20 A ARG 74 -90.19 -151.56 21 A LYS 33 -80.84 -76.80 21 A ASP 52 -48.12 108.37 21 A ARG 74 -90.25 -150.13 22 A LYS 33 -77.22 -77.00 22 A ALA 46 59.17 16.82 22 A ASP 52 -47.19 104.50 23 A LYS 33 -76.12 -72.45 24 A LYS 33 -76.16 -75.81 24 A ASP 52 -47.13 105.62 25 A LYS 33 -74.85 -78.49 25 A ASP 52 -47.06 105.68 25 A ASN 60 61.92 61.39 25 A LEU 73 -79.91 -77.30 25 A ARG 74 -81.04 -93.73 26 A LYS 33 -75.01 -74.98 26 A ASP 52 -47.10 102.93 26 A LEU 73 -77.01 -70.92 26 A ARG 74 -90.24 -150.24 27 A LYS 33 -79.70 -75.08 27 A ASP 52 -48.10 105.77 27 A LEU 73 -80.19 -73.25 27 A ARG 74 -90.21 -150.07 28 A LYS 33 -75.59 -74.86 28 A ASP 52 -46.93 104.77 28 A ASN 60 65.02 64.71 28 A ARG 74 -90.43 -158.46 29 A LYS 33 -74.42 -77.05 29 A ASP 52 -47.17 106.83 29 A ASN 60 62.24 64.85 29 A ARG 74 -90.24 -150.04 30 A LYS 33 -81.96 -72.96 30 A ASP 52 -46.83 104.23 30 A LEU 73 -74.15 -70.50 30 A ARG 74 -90.20 -150.02 31 A LYS 33 -75.93 -76.51 31 A ASP 52 -47.22 105.67 31 A LEU 73 -79.94 -73.62 32 A LYS 33 -80.55 -74.99 32 A ARG 74 -90.11 -151.56 STRUCTURE OF RECOMBINANT HUMAN UBIQUITIN IN AOT REVERSE MICELLES 1 N N A THR 22 A THR 22 HELX_P A GLU 34 A GLU 34 1 1 13 A LEU 56 A LEU 56 HELX_P A ASN 60 A ASN 60 5 2 5 gene regulation, cell cycle reverse micelle, AOT, encapsulation, gene regulation, cell cycle UBIQ_HUMAN UNP 1 1 P62988 MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG 1 76 1G6J 1 76 P62988 A 1 1 76 5 anti-parallel parallel anti-parallel anti-parallel A THR 12 A THR 12 A GLU 16 A GLU 16 A GLN 2 A GLN 2 A LYS 6 A LYS 6 A SER 65 A SER 65 A VAL 70 A VAL 70 A ARG 42 A ARG 42 A PHE 45 A PHE 45 A LYS 48 A LYS 48 A GLN 49 A GLN 49 1 P 1